Navigation Links
Hahnemann University Hospital Granted Magnet(R) Status
Date:12/16/2009

Nursing Care at Hahnemann among the Best in the Nation

PHILADELPHIA, Dec. 16 /PRNewswire-USNewswire/ -- Hahnemann University Hospital proudly announces it has been granted Magnet(R) recognition by the American Nurses Credentialing Center's (ANCC) Magnet Recognition Program(R). Magnet(R) is one of the highest levels of recognition a hospital or medical center can achieve, and places Hahnemann among the five percent of hospitals in the country that have achieved this prestigious distinction.

At 9:00 am on Monday, Hahnemann Administrators and medical staff gathered with employees in the Hospital's Geary Auditorium to hear the official news of the designation directly from the ANCC via conference call.

"Hahnemann is honored to be recognized by such a prestigious organization," stated Stephanie Conners, M.B.A., B.S.N., chief nursing officer. "We have always believed that nursing care at Hahnemann is among the best in the nation and we are thrilled to be granted Magnet(R) status to officially validate our efforts."

The Magnet Recognition Program(R) awards health care organizations that exhibit the highest quality in nursing practice and adherence to national standards for the organization and delivery of nursing services.

Magnet applicants face a stringent evaluation that consists of interviews and an all encompassing evaluation of nursing services. Research has confirmed that there are apparent benefits to hospitals that are awarded Magnet(R) status and to the communities they serve:

  • Healthcare consumers have more confidence in the overall quality of a hospital if it has achieved the level of excellence established by the Magnet Recognition Program.
  • Magnet recognized facilities consistently outperform other facilities in recruiting and retaining nurses resulting in increased stability in patient care and patient satisfaction.
  • Because quality nursing is one of the most important factors in enlisting high caliber physicians and specialists, Magnet status becomes an attractive force that extends to the entire facility.

"Being granted Magnet(R) status is an honor made possible by the hard work and dedication of everyone at Hahnemann, and their ability and desire to work together as a team to provide the best environment for our patients," stated Michael P. Halter, FACHE, chief executive officer.

ANCC is the largest and most prominent nursing credentialing organization in the United States. Hahnemann University Hospital's Magnet(R) status is valid for four years.

Hahnemann University Hospital is a 540-bed academic medical center at Broad and Vine Streets in Philadelphia, Pa. The hospital is a tertiary care institution that specializes in cardiac services, heart failure and transplantation, OB/GYN, orthopedics, medical, surgical and radiation oncology, bone marrow transplantation, renal dialysis and kidney/pancreas/liver transplantation. Hahnemann is recognized by the American Heart Association as a leader in coronary artery disease and heart failure treatments. The hospital performed one of the city's first kidney transplants in 1963 and one of the first bone marrow transplants in 1976. Hahnemann became Philadelphia's first Level I Regional Resource Trauma Center for adults in 1986, and since then has been served by MidAtlantic MedEvac, an aeromedical transport program for critically ill patients. Hahnemann is proud to be the first hospital in Philadelphia to join with The Wellness Community of Philadelphia to offer onsite support and education services to cancer patients and their families. Hahnemann is fully accredited by the Joint Commission on the Accreditation of Healthcare Organizations, the nation's oldest and largest hospital accreditation agency. An affiliate of Drexel University College of Medicine, Hahnemann University Hospital is part of Tenet Pennsylvania, which also includes St. Christopher's Hospital for Children. To learn more about Hahnemann, visit www.hahnemannhospital.com

SOURCE Hahnemann University Hospital


'/>"/>
SOURCE Hahnemann University Hospital
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Indiana Industry, University and Community Leaders Capitalize on Next Generation of States Life Sciences Growth
2. AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease
3. Nikon Corporation Acquires License From Harvard University For STORM Super Resolution Microscopy -- Will Create Innovative New N-STORM Microscope
4. Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology
5. iSirona Announces Go-live at University Hospitals in Cleveland
6. Arts Way Manufacturing Announces Contract for Modular Swine Facility for the University of Georgia
7. WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip(TM) Nano-Dispenser with WaferGens SmartChip(TM) High-throughput Real-Time PCR System
8. New Program to Bring University of Florida Incubator Companies Millions in New Contracts
9. University of Massachusetts Amherst and ADVENTUS Recognize Future Environmental Science Leaders
10. Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology'
11. Texas State University Prepares for Phase 2 Research on the Potential New Cancer and HIV Fighting ALKA-V6 Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... , ... June 24, 2016 , ... While the majority ... as the Cary 5000 and the 6000i models are higher end machines that use ... height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... MA (PRWEB) , ... June 23, 2016 , ... ... Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute ... platform of microbial tests introduced last year,” stated Bob Salter, Vice President of ...
Breaking Biology Technology:
(Date:6/22/2016)... ANGELES , June 22, 2016 /PRNewswire/ ... identity management and verification solutions, has partnered ... edge software solutions for Visitor Management, Self-Service ... provides products that add functional enhancements ... partnership provides corporations and venues with an ...
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):